1. Home
  2. LAW vs VNDA Comparison

LAW vs VNDA Comparison

Compare LAW & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CS Disco Inc.

LAW

CS Disco Inc.

N/A

Current Price

$5.72

Market Cap

286.9M

Sector

Technology

ML Signal

N/A

Logo Vanda Pharmaceuticals Inc.

VNDA

Vanda Pharmaceuticals Inc.

N/A

Current Price

$3.67

Market Cap

231.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LAW
VNDA
Founded
2013
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
286.9M
231.0M
IPO Year
2021
2005

Fundamental Metrics

Financial Performance
Metric
LAW
VNDA
Price
$5.72
$3.67
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$8.00
★ $11.50
AVG Volume (30 Days)
291.8K
★ 1.2M
Earning Date
11-04-2026
10-28-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 22.58
N/A
EPS
★ N/A
N/A
Revenue
$156,849,000.00
★ $216,105,000.00
Revenue This Year
$12.74
$12.05
Revenue Next Year
$10.55
$30.61
P/E Ratio
★ N/A
N/A
Revenue Growth
8.29
★ 8.72
52 Week Low
$2.45
$3.57
52 Week High
$9.11
$9.91

Technical Indicators

Market Signals
Indicator
LAW
VNDA
Relative Strength Index (RSI) 55.90 36.09
Support Level $3.49 $3.57
Resistance Level $6.39 $5.49
Average True Range (ATR) 0.37 0.22
MACD -0.02 0.01
Stochastic Oscillator 44.97 14.29

Price Performance

Historical Comparison
LAW
VNDA

About LAW CS Disco Inc.

CS Disco Inc provides a cloud-native, artificial intelligence-powered legal solution that simplifies discovery, legal document review, and case management for enterprises, law firms, legal services providers, and governments. Its revenue-generating activities directly relate to the sale and support of legal solutions. It has two primary types of contractual arrangements: usage-based and subscription solutions. The usage-based revenue is derived from contracts under which customers are billed monthly based on their usage. Subscription revenue is derived from contracts where customers are contractually committed to a minimum data volume over a period of time.

About VNDA Vanda Pharmaceuticals Inc.

Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include ASO Molecules, VQW-765, Tradipitant, and VTR-297. The maximum of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.

Share on Social Networks: